How M.D. was paid
$4.3M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| E. Rand Sutherland, M.D.Chief Executive Officer | $650,000 | $3,300,350 | $341,250 | $10,500 | $4,302,100 |
| Michael Paul Gray, M.B.A.Chief Financial Officer and Chief Operating Officer | $490,000 | $1,287,137 | $205,800 | $10,500 | $1,993,437 |
| Aaron Deykin, M.D.Chief Medical Officer and Head of Research and Development | $515,000 | $1,089,116 | $216,300 | $10,500 | $1,830,916 |
What changed and why
- $4.3MCEO total compensation decreased to $4,302,100 in fiscal 2025 from $9,108,953 in fiscal 2024.
- $3.3MOption awards for the CEO totaled $3,300,350 during fiscal 2025.
- 105%The board determined that the company achieved 105 percent of corporate goals for 2025.
- Executive compensation is structured around base salary, annual cash bonuses, and stock options.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.